Your browser doesn't support javascript.
loading
Adjuvant Imatinib in Patients with GIST Harboring Exon 9 KIT Mutations: Results from a Multi-institutional European Retrospective Study.
Vincenzi, Bruno; Napolitano, Andrea; Fiocco, Marta; Mir, Olivier; Rutkowski, Piotr; Blay, Jean-Yves; Reichardt, Peter; Joensuu, Heikki; Fumagalli, Elena; Gennatas, Spyridon; Hindi, Nadia; Nannini, Margherita; Spalato Ceruso, Mariella; Italiano, Antoine; Grignani, Giovanni; Brunello, Antonella; Gasperoni, Silvia; De Pas, Tommaso; Badalamenti, Giuseppe; Pantaleo, Maria A; van Houdt, Winan J; IJzerman, Nikki S; Steeghs, Neeltje; Gelderblom, Hans; Desar, Ingrid M E; Falkenhorst, Johanna; Silletta, Marianna; Sbaraglia, Marta; Tonini, Giuseppe; Martin-Broto, Javier; Hohenberger, Peter; Le Cesne, Axel; Jones, Robin L; Dei Tos, Angelo P; Gronchi, Alessandro; Bauer, Sebastian; Casali, Paolo G.
Afiliación
  • Vincenzi B; Medical Oncology, Università Campus Bio-Medico, Rome, Italy.
  • Napolitano A; Medical Oncology, Università Campus Bio-Medico, Rome, Italy.
  • Fiocco M; Sarcoma Unit, Royal Marsden Hospital NHS Trust, London, United Kingdom.
  • Mir O; Biomedical Statistics and Data Science, Mathematical Institute Leiden University, Leiden, the Netherlands.
  • Rutkowski P; Sarcoma Group, Gustave Roussy, Villejuif, France.
  • Blay JY; Department of Bone/Soft Tissue Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
  • Reichardt P; Medical Oncology, Center Léon Bérard, Lyon, France.
  • Joensuu H; HELIOS Clinic Berlin Buch, Berlin, Germany.
  • Fumagalli E; Oncology, Helsinki University Central Hospital and University of Helsinki, Helsinki, Finland.
  • Gennatas S; Medical Oncology Unit 2, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
  • Hindi N; Sarcoma Unit, Royal Marsden Hospital NHS Trust, London, United Kingdom.
  • Nannini M; Biomedicine Institute of Seville/Virgen del Rocío University Hospital, Sevilla, Spain.
  • Spalato Ceruso M; DIMES, University of Bologna, Bologna, Italy.
  • Italiano A; Sarcoma Unit, Institut Bergonié, Bordeaux, France.
  • Grignani G; Sarcoma Unit, Institut Bergonié, Bordeaux, France.
  • Brunello A; Medical Science Faculty, University of Bordeaux, Bordeaux, France.
  • Gasperoni S; Medical Oncology, Candiolo Cancer Institute FPO-IRCCS, Candiolo, Italy.
  • De Pas T; Division of Medical Oncology, Istituto Oncologico Veneto- IRCCS, Padova, Italy.
  • Badalamenti G; Translational Oncology Unit, University Hospital Careggi, Firenze, Italy.
  • Pantaleo MA; Medical Oncology for Melanoma & Sarcoma, IEO - European Institute of Oncology IRCCS, Milan, Italy.
  • van Houdt WJ; Medical Oncology, University of Palermo, Palermo, Italy.
  • IJzerman NS; DIMES, University of Bologna, Bologna, Italy.
  • Steeghs N; Surgical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Gelderblom H; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Desar IME; Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Falkenhorst J; Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Silletta M; Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands.
  • Sbaraglia M; Medical Oncology, Radboud University Medical Centre, Nijmegen, the Netherlands.
  • Tonini G; Medical Oncology, University Hospital Essen, Essen, Germany.
  • Martin-Broto J; Medical Oncology, Università Campus Bio-Medico, Rome, Italy.
  • Hohenberger P; Pathological Anatomy, Azienda Ospedaliera di Padova, Padua, Italy.
  • Le Cesne A; Medical Oncology, Università Campus Bio-Medico, Rome, Italy.
  • Jones RL; Biomedicine Institute of Seville/Virgen del Rocío University Hospital, Sevilla, Spain.
  • Dei Tos AP; Division of Surgical Oncology and Thoracic Surgery, University Medical Center Mannheim, University of Heidelberg, Mannheim, Germany.
  • Gronchi A; Sarcoma Group, Gustave Roussy, Villejuif, France.
  • Bauer S; Sarcoma Unit, Royal Marsden Hospital NHS Trust, London, United Kingdom.
  • Casali PG; Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom.
Clin Cancer Res ; 28(8): 1672-1679, 2022 04 14.
Article en En | MEDLINE | ID: mdl-34615721
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Tumores del Estroma Gastrointestinal / Antineoplásicos Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Italia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Tumores del Estroma Gastrointestinal / Antineoplásicos Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Italia